Highly polymorphic products of both HLA-DR and HLA-DQ genes contribute to the polymorphism of the HLA-DR w13 haplotype

Jean Michon(Université Paris Sciences et Lettres), J P Lévy(Centre National de la Recherche Scientifique), Ghislaine Sterkers(Délégation Paris 7), L. Gebuhrer(Inserm), C. Freide(Institut National de la Transfusion Sanguine), H Bétuel(Hôpital Cochin), J. Y. Muller, Yvette Hénin(Centre National de la Recherche Scientifique)

Immunogenetics

September 1, 1986

10.1007/bf00364746

Cited by 6

Related Papers

Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations

|Nature Genetics|2015|563

Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients

|Blood|2006|431

Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents

|Blood|2006|362

Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study

|The Lancet Oncology|2009|196

CARD15/NOD2 Is Required for Peyer's Patches Homeostasis in Mice

|PLoS ONE|2007|139